In conclusion, current cross-sectional study in a large Chinese population revealed that serum complement C3 level is positively associated with prevalence and severity of NAFLD, and this association is independent of obesity and metabolic syndrome. This evidence concerns the gene C3 and metabolic dysfunction-associated steatotic liver disease.